Antimicrobial resistance (AMR) is a pressing global health issue where microorganisms like bacteria, viruses, fungi, and parasites develop resistance to the medications used to treat them. This phenomenon poses a significant threat to public health, making infections harder to treat and increasing the risk of illness, severe complications, and death. Overuse and misuse of antibiotics in humans, animals, and agriculture contribute to the acceleration of AMR. Combatting this challenge requires a multifaceted approach, including responsible antibiotic use, better hygiene practices, development of new antibiotics, and global collaboration among healthcare sectors. Addressing antimicrobial resistance is crucial to preserving the effectiveness of existing treatments and ensuring our ability to fight infectious diseases effectively in the future.
Title : Novel regulatory mechanisms of innate immunity and inflammation
Ping Xie, Rutgers University, United States
Title : Human challenge clinical trial of vaccines for infectious diseases – A necessary evil
Sudhakar Bangera, AILEEN Clinical Research Services, India
Title : Your vaccine attitude determines your altitude. What are the determinants of attitudes toward vaccination
Vincenzo Alfano, University of Napoli Parthenope, Italy
Title : Neutralizing antibodies response to SARS-COV-2 XBB1.5 mRNA vaccine in nephrology patients on dialysis against different viral variants
Agostino Riva, University of Milan, Italy
Title : Why Antimicrobial Resistance is a Global Threat and Its Impact On Everyone
Regina Au, BioMarketing Insight, United States
Title : The influence of physical factors on recombinant human serum albumin
Patrycja Dolibog, Medical University of Silesia in Katowice, Poland
Title : Current investments and future directions of biomedical advanced research and development authority’s CBRN vaccines portfolio
Lindsay Parish, BARDA, United States
Title : Development and characterization of a virus-like particle-based subunit vaccine candidate against Indian isolate of Porcine Circovirus 2d
Rajib Deb, ICAR-National Research Centre on Pig, India
Title : The Ethiopian vaccine supply chain and logistics system’s performance after the last mile delivery initiative: Phenomenological study
Samson Gebremedhin Gebreselassie, Project HOPE, Ethiopia
Title : Limits of vaccine quality control in India: Possible solutions
Bhoj R Singh, Indian Veterinary Research Institute, India